For example while ovarian cancers have been shown to display high levels of both RhoGDI [21, 22] and D4-GDI [23] compared to normal tissue; RhoGDI has been shown to be under expressed in both primary non-small cell lung cancer (NSCLC) and malignant gliomas [24, 25]. Here, ARHGDIA is linked to malignant glioma.